NCT00590109View on ClinicalTrials.gov

Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer

CompletedOBSERVATIONAL
Enrollment

383

Participants

Timeline

Start Date

March 31, 1997

Primary Completion Date

December 22, 2021

Study Completion Date

December 22, 2021

Conditions
Breast Cancer
Interventions
OTHER

Blood test

subjects will provide one 8ml blood sample drawn into one ACD tube and 16ml of blood drawn into two EDTA (purple top) tubes.

OTHER

Questionnaire

A questionnaire encompassing medical, environmental exposure, and reproductive history.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
collaborator

Sarah Lawrence College

OTHER

collaborator

University of Washington

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER